Ford Robert B 4
4 · ABBOTT LABORATORIES · Filed Feb 7, 2025
Insider Transaction Report
Form 4
Ford Robert B
DirectorCHAIRMAN AND CEO
Transactions
- Exercise/Conversion
Common shares without par value
2025-02-05$38.40/sh+285,388$10,958,899→ 505,447 total - Sale
Common shares without par value
2025-02-05$131.17/sh−285,388$37,435,200→ 220,059 total - Exercise/Conversion
Option (right to buy)
2025-02-05−285,388→ 0 totalExercise: $38.40From: 2019-02-19Exp: 2026-02-18→ Common Shares (285,388 underlying)
Holdings
- 197,403(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.68 to $131.38, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Held in the Ford Family Trust DTD June 2, 2014. The reporting person is co-trustee of the trust.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.